Showing posts with label FDA. Show all posts
Showing posts with label FDA. Show all posts

Tuesday, December 28, 2010

FDA warnings in 2010!!


There has been quite a few warnings ... and threat from FDA about drugs...in 2010. 


The most popular news of the year among drug warnings was a repeat FDA warning that off-label use of quinine for leg cramps may result in serious and life-threatening hematologic adverse effects.
Among other drug alerts, the FDA warned against taking 
* Long acting beta agonists (LABA) by themselves should not be taken for a long time by asthma patients, unless their symptoms are not controlled by other medications (like steroids)
*80-mg dose of simvastatin is associated with an increased risk for myopathy, including rhabdomyolysis 
*Opioid tramadol is linked to increased suicide risk
*Bisphosphonates used to treat osteoporosis have a possible increased risk for 2 types of atypical femur fractures(femoral subtrochanteric and femoral diapyseal fractures)...both of which account for <1% of all femoral/hip fractures overall.
*Rosiglitazone(Avandia) was allowed to remain available under a stringent restricted-access program, despite adverse cardiovascular effects 
* Tigecycline was linked to an increased risk for death in patients with certain severe infections.(probably because its bacteriostatic)
* A threat from FDA to withdraw Midodrine from the market....and a later "U" turn by FDA...allowing it to stay in the market (no idea what's happening!)


May be ARBs and cancer risk might be on the agenda for 2011!!

Monday, September 13, 2010

what is it with Cranberry juice and warfarin!

Anticoagulation clinic!! - a place to advice patients about diet, and monitoring treatment closely. Today..I had a patient ask me about Cranberry and products ..and taking them with warfarin. Well..I didnt know the right answer. She has an aunt diagnosed with cancer..and she would like to take cranberry for its antioxidant/anticancer property. So ..I delved into some evidence.....
What does FDA say -  In 2006, FDA issued warning about a potential interaction between the two in raising the INR. This was based on a UK health committee's warning about the same interaction. The warning came after 12 reports of a suspected interaction!! (Just 12 reports...without any base??)


What is the mechanism of interaction - Warfarin  is a racemic mixture of the R- and S-enantiomers, with the S-enantiomer having 2-5 times more anticoagulant activity.It was proposed that some Flavinoids in Cranberry products might inhibit cytochrome P450 (CYP) 2C9, the enzyme responsible for the hepatic elimination of S-warfarin. But many studies have shown  no effect on CYP2C9(J of Exp Pharm 2010), although some questionable effect on the less important enzyme, CYP3A4(Drug Met & Dis 2009)


What does evidence say -  The same year as FDA put up the warning...the first randomised trial on this was published( J of Amer Diet Asssoc,2006). Just with 7 patients...taking 250cc of Cranberry juice /day......no difference in INR was found during 3 months duration. Another study in Clin Pharm in 2009 showed no difference in INR among warfarin pts taking 240cc/day of cranberry juice Vs placebo for 2 weeks.
A recent review in Amer J of Medicine concluded that no interaction exists between warfain and Cranberry products consumed in moderation (around 250cc/day). We don't know about excessive consumption though.
So, thats pretty much it......... SAFE to tahe warfarin and Cranberry products (may be < 300 cc/day). Anticoagulants like Dabigatran are on the horizon...which might have less interaction...and would be the way forward.

Thursday, September 2, 2010

Midodrine may not be there!

The latest medication which has come under FDA's radar in the last month...is the drug that has been increasingly used by nephrologists and heaptologists--- MIDODRINE .
On Aug 17th 2010 FDA issued a proposal to withdraw midodrine from the market within 30 days. 
So I decided to look into the evidence behind using Midodrine. 
Let me start with a little background on Midodrine---- It is a alpha agonist, and acts on venous and arteriolar vasculature producing increased vascular tone. It increases sitting, standing and lying BP.So the most common side effect reported is supine hypertension.


It is surprising that there is very scarce data on the clinical effectiveness of Midodrine. So far 3 randomised trials have been done. One is 3 weeks duration, and the other two are of 1-2 days duration!!! All studies were done on patients with orthostatic hypotension .
In the 3 week trial(JAMA 1997), pts on Midodrine(10 mg tid) had significantly higher (by about 20 mmHg) 1-minute standing systolic pressure 1 hour after dosing (blood pressures were not measured at other times) for all 3 weeks.They also had a similar increase in supine and sitting BP. And 25% of the 82 pts on Midodrine  dropped out of the study(due to pilomotor reactions, supine HTN, urinary retention)
The 1 & 2 day study also showed similar improvements in standing BP.In 1 day study the supine BP was >200 systolic in 22% pts on 10mg and 45% pts on 20mg. This elevated BP lasted for 6 hours after the dose. 


The only indication midodrine is approved is for Orthostatic hypotension. This has been extrapolated, and has been commonly used in one other setting...which is for treating hypotension during dialysis. There are nearly 10 studies on this..but again..the largest of these studies had 21 participants, and with short follow up. Have a look at this review from 2004. 


So there seems to be no real convincing data to support Midodrine. The Shire pharmaceuticals agreed to perform post marketing trials..but failed to do any. And thats the reason for FDA's proposal. It seems unlikely that Midodrine will be available in the near future(as early as this month).So what this means is..that physicians and patients on Midodrine have to be prepared to find an alternated  drug pretty soon!